Amass *Core
Eight specialised data layers. One retrieval engine.
One query searches literature, trials, drugs, genes, patents, and regulatory docs in parallel. Every answer cites its source — a DOI, NCT ID, or patent number. No hallucination.
Architecture
How a query fans out and comes back cited
You send one natural-language query. The engine dispatches to every relevant layer simultaneously, merges results, and returns a single JSON response with citations attached to each claim.
Data Sources
Amass *Core Engine
BiomedCore
40M+
PatentCore
16M+
RegulatoryCore
FDA + EMA
DrugCore
22K+
TrialCore
1.2M+
GeneCore
43K+
Cited Outputs
BiomedCore
PubMed & PMC papers indexed
BiomedCore
40M+ PubMed and PMC papers — full text, MeSH-indexed
- Full PubMed and PubMed Central coverage — abstracts and full text
- Citation counts, journal impact metrics, and quality signals
- Ideal for systematic literature reviews and evidence synthesis
- MeSH-enriched metadata for precise filtering
SGLT2 inhibitors in heart failure with preserved ejection fraction
Solomon SD, McMurray JJV, et al.
N Engl J Med (2024)
PatentCore
Life-science patents indexed
PatentCore
16M+ patent publications — full text, families, and cross-links to drugs and papers
- 16.8M publications across every major office — US, EP, WIPO/PCT, CN, JP, KR, and more
- Full-text search over title, abstract, claims, and description
- CPC/IPC classifications, assignees, inventors, and four dates — priority, filing, publication, grant
- Search collapses each family to one publication, so a landscape isn't flooded with near-duplicates
- 12.5M patents linked to a drug in DrugCore; citation lineage and references into BiomedCore
GLP-1 analogues and derivatives
Assignee: Novo Nordisk A/S
Filed: 2010-12-16
RegulatoryCore
FDA & EMA documents indexed
RegulatoryCore
FDA and EMA on one schema — approvals, labels, EPARs, and designations
- FDA application records, drug labels, review documents, and approval letters
- EMA EPARs, assessment reports, and SmPCs — European authorizations in full
- Unified authorization status, plus Breakthrough, PRIME, and Accelerated Approval designations
- Orphan tracking, cross-linked to the drug each authorization covers in DrugCore
Donanemab (Kisunla)
Early symptomatic Alzheimer's disease
Approved: 2024-07-02
DrugCore
ChEMBL drugs & molecules indexed
DrugCore
22K+ harmonized drugs and molecules — modality, clinical stage, and structure
- ChEMBL-derived drug records — names, trade names, and synonyms, harmonized
- Chemical structures with InChIKey and SMILES, plus modality classification
- Highest clinical stage reached, from preclinical through approval
- Parent/child relationships, cross-linked to trials, literature, and regulatory records
Semaglutide
Ozempic · Wegovy · Rybelsus
6 approved · 30 investigational
TrialCore
Clinical trials indexed
TrialCore
1.2M+ trials from ClinicalTrials.gov and international registries — status, endpoints, sponsor
- ClinicalTrials.gov + international registries — 590K+ and 610K+ — with AI-enhanced search
- Enrollment status, endpoints, and sponsor intelligence
- Phase, indication, and comparator filtering
- Trial-to-publication linking for evidence completeness
NCT04931681
Semaglutide vs placebo in NASH with fibrosis
Sponsor: Novo Nordisk
GeneCore
Human genes indexed
GeneCore
43K+ harmonized human genes — druggability, constraint, and cross-linked to DrugCore
- HGNC, NCBI, UniProt, and Open Targets — harmonized on one schema
- Druggability and tractability assessments from Open Targets
- Genetic constraint via gnomAD v4.0 — pLI and LOEUF loss-of-function scores
- Cellular essentiality from DepMap CRISPR screens — genes required for cell survival
- Each gene cross-links to the drugs that target it in DrugCore, and the trials and papers studying it
Capabilities
What you get back from every query
Cited answers
Every claim traces back to a source document. Inline citations, not hallucinated references.
Unified retrieval
Query once. Eight layers respond in parallel. No need to stitch results across different databases.
Agent execution
Built-in agents plan multi-step research workflows, iterate on results, and deliver structured output.
Enterprise controls
Role-based access, audit logging, and data residency options for regulated environments.
API & MCP access
REST API for custom integrations. MCP server for Claude, ChatGPT, and Cursor — same engine, your interface.
Structured outputs
Tables, JSON, and tagged extracts. Get machine-readable results, not just paragraphs of text.
Get started
Query 500M+ documents from your terminal in five minutes
Get your first cited response in under five minutes. No prior knowledge of the data layers required.